in 2011, the acronym was to describe the shared five clinical features (telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting) presented in six patients (1). This evidence concerns the gene EPO and Telangiectasia.